Metraipolis › archive › dc_6b26014ee59e

Computational repurposing of approved drugs targeting KRAS G12D and EGFR for colorectal cancer therapy — Europe PMC PMID:41604371

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41604371
DOI
10.1371/journal.pone.0338123
License (as archived)
solo-consultazione
Archived
2026-11-06T11:32:02.294Z
SHA-256 of the archived text
cb0e18e073a6b0ad77288cba9efd0e4a064a94b23962771a105d3dca7ab392e3
Stable URL of this page
https://metraipolis.com/documento/dc_6b26014ee59e

How to cite

Computational repurposing of approved drugs targeting KRAS G12D and EGFR for colorectal cancer therapy — Europe PMC PMID:41604371 — Europe PMC (en), https://europepmc.org/article/MED/41604371 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6b26014ee59e (Metraipolis archive dc_6b26014ee59e, sha256 cb0e18e073a6b0ad77288cba9efd0e4a064a94b23962771a105d3dca7ab392e3)
BibTeX
@misc{dc6b26014ee59e,
  title = {Computational repurposing of approved drugs targeting KRAS G12D and EGFR for colorectal cancer therapy — Europe PMC PMID:41604371},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41604371},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6b26014ee59e; sha256 cb0e18e073a6b0ad77288cba9efd0e4a064a94b23962771a105d3dca7ab392e3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41604371. Agents can read the archived copy with the MCP tool read_document.